Wajd Alkabbani, PhD

Brigham and Women's Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• 4E-05 - A data mining application tool to detect safety signals of sodium glucose cotransporter 2 inhibitors in patients with type 2 diabetes and chronic kidney disease.

  Monday, August 25, 2025
  5:15 PM - 5:30 PM ET

• 5E-06 - Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in patients with Type 2 Diabetes

  Tuesday, August 26, 2025
  9:45 AM - 10:00 AM ET